677704-57-3

Basic information

• Product Name: Benzonitrile, 4-(4-morpholinyl)-3-(trifluoromethyl)-
• CAS NO: 677704-57-3
• Molecular Formula: C12H11F3N2O
• Molecular Weight: 256.227
• Mol File: 677704-57-3.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: Benzonitrile, 4-(4-morpholinyl)-3-(trifluoromethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 4-(4-morpholinyl)-3-(trifluoromethyl)-(677704-57-3)
• EPA Substance Registry System: Benzonitrile, 4-(4-morpholinyl)-3-(trifluoromethyl)-(677704-57-3)

Safety Data

• Hazardous Substances Data: 677704-57-3(Hazardous Substances Data)

Upstream product

• 110-91-8 morpholine 
• 67515-59-7 4-Fluoro-3-(trifluoromethyl)benzonitrile 
• 1735-53-1 4-bromo-3-(trifluoromethyl)benzonitrile 

Downstream Products

• 1035217-18-5 (E)-N'-hydroxy-4-morpholino-3-(trifluoromethyl)benzimidamide 
• 1035217-18-5 (Z)-N'-hydroxy-4-morpholino-3-(trifluoromethyl)benzimidamide 
• 1035217-18-5 N'-hydroxy-4-morpholino-3-(trifluoromethyl)benzimidamide 
• 1318241-82-5 4-(cyclopropylamino)-N-(2-methyl-5-(4-morpholino-3-(trifluoromethyl)benzamido)phenyl)thieno[3,2-d]pyrimidine-7-carboxamide 
• 1318243-00-3 N-(3-amino-4-methylphenyl)-4-morpholino-3-(trifluoromethyl)benzamide 
• 1318242-99-7 N-(4-methyl-3-nitrophenyl)-4-morpholino-3-(trifluoromethyl)benzamide 
• 1241911-23-8 (4-morpholino-3-(trifluoromethyl)phenyl)methanamine 
• 1140461-83-1 methyl 4-morpholino-3-(trifluoromethyl)benzoate 
• 677704-58-4 4-(morpholin-4-yl)-3-(trifluoromethyl)benzoic acid 

Relevant articles and documents

OXADIAZINONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES

The present invention includes name compounds of general formula (I) in which R1, Y, and R3 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compos

NOVEL BRONCHODILATING DIAZAHETEROARYLS

The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.

THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON PROTEIN KINASES

The present invention relates to a thieno[3,2-d]pyrimidine derivative of formula (I), or a pharmaceutically acceptable salt, hydrate or solvate thereof, which has an excellent inhibitory activity on protein kinases, and a pharmaceutical composition comprising the same is effective in preventing or treating abnormal cell growth diseases.